Clinical Trials Browser

Has results × Carcinoma, Non-Small-Cell Lung × Ado-Trastuzumab Emtansine × Clear all

NCT02289833 2019-08-07

A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor (HER)2 Immunohistochemistry (IHC)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Completed

49 enrolled 22 charts

Carcinoma, Non-Small-Cell Lung